journal of daily browsing (broken links intentionally preserved to evidence the effects of internet censorship)
Osiris Leaps on $1.38 Billion Genzyme Stem-Cell Deal (Update1) By Elizabeth LopattoNov. 4 (Bloomberg) -- Osiris Therapeutics Inc. rose the most in 19 months in Nasdaq Stock Market trading after Genzyme Corp. agreed to pay the company as much as $1.38 billion to develop two experimental drugs using adult stem cells.... the other Osiris un-nefer ...:)
Labels: (.)(.)
Subscribe to Posts [Atom]
View my complete profile